BioCentury
ARTICLE | Company News

Caprion, J&J deal

April 9, 2001 7:00 AM UTC

JNJ's Ortho-Clinical Diagnostics Inc. division (Raritan, N.J.) received an option to license Caprion's prion technologies, including monoclonal antibodies to detect new variant Creutzfeldt-Jacob's dis...